Actavis - Company & Market Research Reports

Actavis develops, manufactures, and commercializes generic and branded pharmaceutical products and medical devices. It offers products in central nervous system, eye care, medical aesthetics, gastroenterology, women’s health, urology, cardiovascular, and anti-infective therapeutic categories. The company was incorporated in 2005 and is based in Parsippany, New Jersey. It has global headquarters in Dublin, Ireland.

Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors - Product Thumbnail Image

Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors

  • Report
  • 70 Pages
From
Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018 - Product Thumbnail Image

Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018

  • Report
  • 344 Pages
From
The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition - Product Thumbnail Image

The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition

  • Report
  • 195 Pages
From
Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2012-2018 - Product Thumbnail Image

Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2012-2018

  • Report
  • 2500 Pages
From
Hormone Replacement Therapy (HRT) - Global Strategic Business Report - Product Thumbnail Image

Hormone Replacement Therapy (HRT) - Global Strategic Business Report

  • Report
  • 198 Pages
From
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 - Product Thumbnail Image

Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018

  • Report
  • 1600 Pages
From
Global Osteoporosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025 - Product Thumbnail Image

Global Osteoporosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • Report
From
Buccal Drug Delivery Systems: Opportunities And Challenges In Buccal, Sublingual Films, Tablets & Sprays  - Detailed Analysis On Technologies And Pipeline Development - Product Thumbnail Image

Buccal Drug Delivery Systems: Opportunities And Challenges In Buccal, Sublingual Films, Tablets & Sprays - Detailed Analysis On Technologies And Pipeline Development

  • Report
  • 70 Pages
From
Human Reproductive Technologies - Global Strategic Business Report - Product Thumbnail Image

Human Reproductive Technologies - Global Strategic Business Report

  • Report
  • 308 Pages
From
The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others) - Product Thumbnail Image

The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others)

  • Report
  • 195 Pages
From
Global Breast Cancer Monoclonal Antibodies Market 2016-2020 - Product Thumbnail Image

Global Breast Cancer Monoclonal Antibodies Market 2016-2020

  • Report
  • 88 Pages
From
Osteoporosis Drugs Market Analysis By Product (Branded, Bisphosphonates, Parathyroid Hormone Therapy, Calcitonin, Selective Estrogen Inhibitors Modulator (SERM), Rank Ligand Inhibitors, Generics), And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

Osteoporosis Drugs Market Analysis By Product (Branded, Bisphosphonates, Parathyroid Hormone Therapy, Calcitonin, Selective Estrogen Inhibitors Modulator (SERM), Rank Ligand Inhibitors, Generics), And Segment Forecasts, 2014 - 2025

  • Report
  • 78 Pages
From
Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 - Product Thumbnail Image

Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018

  • Report
  • 1000 Pages
From
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018 - Product Thumbnail Image

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018

  • Report
  • 457 Pages
From
Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018 - Product Thumbnail Image

Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018

  • Report
  • 950 Pages
From
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018 - Product Thumbnail Image

Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018

  • Report
  • 2000 Pages
From
Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018 - Product Thumbnail Image

Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2012- 2018

  • Report
  • 1000 Pages
From
Hormone Replacement Therapy Market: By Product; By Route, By Disease & By Region - Forecast 2016-2021 - Product Thumbnail Image

Hormone Replacement Therapy Market: By Product; By Route, By Disease & By Region - Forecast 2016-2021

  • Report
  • 149 Pages
From
Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018 - Product Thumbnail Image

Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018

  • Report
  • 1500 Pages
From
Sustained Release Ocular Drug Delivery Systems, 2015 - 2025 (2nd edition) - Product Thumbnail Image

Sustained Release Ocular Drug Delivery Systems, 2015 - 2025 (2nd edition)

  • Report
  • 275 Pages
From
Loading Indicator
adroll